Society guideline links: Mucopolysaccharidoses

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Inborn errors of metabolism".)

International

●Expert recommendations for the laboratory diagnosis of MPS VI (2012)

●International Consensus Panel on the Management and Treatment of Mucopolysaccharidosis I: Mucopolysaccharidosis I – Management and treatment guidelines (2009)

United States

●American College of Medical Genetics and Genomics (ACMG): Treatment of mucopolysaccharidosis type II (Hunter syndrome) – A Delphi derived practice resource (2020)

●ACMG: Newborn screening ACTion (ACT) sheet on [alpha-L-iduronidase deficiency/with or without glycosaminoglycans (GAG)] mucopolysaccharidosis type 1 (MPS I) (2020)

●ACMG: Lysosomal storage diseases – Diagnostic confirmation and management of presymptomatic individuals (2011)

Europe

●European recommendations for the diagnosis and multidisciplinary management of a rare disease – Mucopolysaccharidosis type II (2011)

United Kingdom

●British Inherited Metabolic Diseases Group (BIMDG): Guidance for the treatment of mucopolysaccharidosis type I (MPS I) (2020)